The Oncology Institute, Inc. (STLN) — Cash Flow Quality Index

Latest as of December 2022: -37.27x

The Oncology Institute, Inc. (STLN) has a Cash Flow Quality Index of -37.27x as of December 2022. Operating cash flow of $-61.76 Million is below net income of $1.66 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore debt repayment capacity of The Oncology Institute, Inc. to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-37.27x
Operating CF / Net Income

Operating Cash Flow

$-61.76 Million
USD

Net Income

$1.66 Million
USD

Data as of

Dec 2022
Most recent filing

The Oncology Institute, Inc. Cash Flow Quality Index (2022–2022)

Historical Cash Flow Quality Index for The Oncology Institute, Inc. across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. See net asset quality index of The Oncology Institute, Inc. to measure how much of total assets are equity-financed.

Annual Cash Flow Quality Index for The Oncology Institute, Inc. (2022–2022)

Year-by-year earnings quality comparison for The Oncology Institute, Inc.. For the full cash flow conversion analysis, see STLN cash flow conversion.

Year Quality Index Operating CF (USD) Net Income YoY Change
2022 -37.27x $-61.76 Million $1.66 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.